Aigen Investment Management, LP Global Blood Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$22.3 - $37.39 $396,337 - $664,532	17,773 New	17,773 $568,000
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $291,287 - $426,870	-11,432 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$32.46 - $43.42 $371,082 - $496,377	11,432 New	11,432 $400,000
Q1 2021 May 11, 2021	SELL	$38.94 - $50.85 $654,036 - $854,076	-16,796 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $632,369 - $1.07 Million	16,796 New	16,796 $727,000
Q1 2020 May 08, 2020	SELL	$41.72 - $87.2 $6,842 - $14,300	-164 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$45.7 - $81.86 $7,494 - $13,425	164 New	164 $13,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.